TABLE 1.
β-Lactam(s)a | MIC (μg/ml) for:
|
||
---|---|---|---|
C. gleum CIP 103039 | E. coli DH10B(pCGA-1) | E. coli DH10B | |
Amoxicillin | 256 | 512 | 2 |
Amoxicillin-CLA | 256 | 16 | 2 |
Amoxicillin-TZB | 256 | 16 | 2 |
Ticarcillin | 256 | 64 | 2 |
Ticarcillin-CLA | 256 | 4 | 2 |
Ticarcillin-TZB | 256 | 8 | 2 |
Piperacillin | 8 | 8 | 1 |
Piperacillin-TZB | 4 | 2 | 1 |
Cephalothin | 256 | 64 | 2 |
Ceftazidime | 4 | 16 | 0.06 |
Ceftazidime-CLA | 0.5 | 1 | 0.06 |
Ceftazidime-TZB | 0.5 | 0.5 | 0.06 |
Cefotaxime | 32 | 0.5 | 0.06 |
Cefotaxime-CLA | 32 | 0.06 | 0.06 |
Cefotaxime-TZB | 32 | 0.06 | 0.06 |
Cefepime | 1 | 0.5 | 0.06 |
Cefpirome | 2 | 0.5 | 0.06 |
Cefoxitin | 16 | 8 | 4 |
Moxalactam | 16 | 1 | 0.12 |
Aztreonam | >512 | 16 | 0.12 |
Imipenem | 2 | 0.12 | 0.06 |
Meropenem | 8 | 0.06 | 0.06 |
Clavulanic acid (CLA) and tazobactam (TZB) were used at concentrations of 2 and 4 μg/ml, respectively.